Yoshiki Negi

Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non−Small Cell Lung Cancer

Hayato Kawachi, Tadaaki Yamada, Motohiro Tamiya et al. · JAMA Network Open · 2023 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma

Eriko Fujimoto, Takashi Kijima, Kozo Kuribayashi et al. · Expert Review of Anticancer Therapy · 2017 · 25 citations

Medicine, Oncology, Pharmacology +9

Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma

Daisuke Horio, Toshiyuki Minami, Hidemi Kitai et al. · Cancer Science · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest

Hirotoshi Ishigaki, Toshiyuki Minami, Osamu Morimura et al. · Biochemical and Biophysical Research Communications · 2019 · 21 citations

Life Sciences, Cell Biology, Oncology +16

Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma

Y. Nakajima, Kozo Kuribayashi, Hirotoshi Ishigaki et al. · Cancer Investigation · 2020 · 17 citations

Medicine, Oncology, Pathology +15